Virginia Contract Research Organization Co., Ltd. (VCRO) has successfully prepared and submitted Phase II IND package in common technical document (CTD) format to the US FDA with authorization from G&E Herbal Biotechnology Co., Ltd. The Phase II clinical trials which investigate the efficacy and safety of SR-T100 on the treatment for common warts (CW) and genital warts (GW) has been successfully accepted by the US FDA.Related Link:
Congratulations! Phase II IND Package in Common Technical Document (CTD) Accepted by the USA FDA
Virginia Contract Research Organization Co., Ltd. (VCRO) has successfully prepared and submitted Phase II IND package in common technical document (CTD) format to the US FDA with authorization from G&E Herbal Biotechnology Co., Ltd. The Phase II clinical trials which investigate the efficacy and safety of SR-T100 on the treatment for common warts (CW) and…